{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:06:51Z","timestamp":1767168411884,"version":"build-2238731810"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":160,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>\n                    A technique to predict crucial clinical prostate cancer (PC) is desperately required to prevent diagnostic errors and overdiagnosis. To create a multimodal model that incorporates long\u2010established messenger RNA (mRNA) indicators and conventional risk variables for identifying individuals with severe PC on prostatic biopsies. Urinary has gathered for mRNA analysis following a DRE and before a prostatic examination in two prospective multimodal investigations. A first group (\n                    <jats:italic>n<\/jats:italic>\n                    = 489) generated the multimodal risk score, which was then medically verified in a second group (\n                    <jats:italic>n<\/jats:italic>\n                    = 283). The reverse transcription qualitative polymerase chain reaction determined the mRNA phase. Logistic regression was applied to predict risk in patients and incorporate health risks. The area under the curve (AUC) was used to compare models, and clinical efficacy was assessed by using a DCA. The amounts of sixth homeobox clustering and first distal\u2010less homeobox mRNA have been strongly predictive of high\u2010grade PC detection. In the control subjects, the multimodal method achieved a total AUC of 0.90, with the most important aspects being the messenger riboneuclic acid features\u2019 PSA densities and previous cancer\u2010negative tests as a nonsignificant design ability to contribute to PSA, aging, and background. An AUC of 0.86 was observed for one more model that added DRE as an extra risk component. Two methods were satisfactorily verified without any significant changes within the area under the curve in the validation group. DCA showed a massive net advantage and the highest decrease in inappropriate costs.\n                  <\/jats:p>","DOI":"10.1155\/2022\/9223400","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T21:50:07Z","timestamp":1654897807000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Retracted] Developing a Multimodal Model for Detecting Higher\u2010Grade Prostate Cancer Using Biomarkers and Risk Factors"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-1953","authenticated-orcid":false,"given":"Palanivel","family":"Velmurugan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayagam","family":"Mohanavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4476-1832","authenticated-orcid":false,"given":"Anupama","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subpiramaniyam","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-4999","authenticated-orcid":false,"given":"Atif Abdulwahab A.","family":"Oyouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama M.","family":"Al-Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othman R.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-1524","authenticated-orcid":false,"given":"Mohammed I.","family":"Alasseiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Hamadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel Ibrahim","family":"Alalawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"e_1_2_9_1_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361"},{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2018.09.004"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2018.11.001"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0070-9"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.819500"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0369"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5291.1371"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314849.118"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00265-006-0178-0"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2011.07.002"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-012-0277-6"},{"key":"e_1_2_9_14_2","first-page":"313","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends","volume":"170","author":"Walsh P. C.","year":"2003","journal-title":"The Journal of Urology"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0026"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003180"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.07.023"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.07.004"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.063289"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6947.102"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2011.50"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3334"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)64961-9"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-1223"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22925"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.213.2.r99nv26481"},{"key":"e_1_2_9_28_2","first-page":"610","article-title":"A comparison of various supervised machine learning techniques for prostate cancer prediction","volume":"21","author":"Erdem E.","year":"2021","journal-title":"Avrupa Bilim ve Teknoloji Dergisi"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1198\/016214507000000400"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep08758"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13314"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.5526"}],"updated-by":[{"DOI":"10.1155\/2023\/9767949","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"record-id":"57993"},{"DOI":"10.1155\/2023\/9767949","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000}}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2022\/9223400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2022\/9223400.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2022\/9223400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T03:00:12Z","timestamp":1735614012000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2022\/9223400"}},"subtitle":[],"editor":[{"given":"Yuvaraja","family":"Teekaraman","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1155\/2022\/9223400"],"URL":"https:\/\/doi.org\/10.1155\/2022\/9223400","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2022-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"9223400"}}